M.tb ag85c modified at c209 by adamantyl-ebselen Deposition Author(s): Goins, C.M. , Ronning, D.R.
Date: 2016-07-18 Method: X-RAY DIFFRACTION Resolution: 1.3 Å Organism(s): Mycobacterium Tuberculosis Sequences Data: 5KWI_A
M.tb ag85c modified at c209 by amino-ebselen Deposition Author(s): Goins, C.M. , Ronning, D.R.
Date: 2016-07-18 Method: X-RAY DIFFRACTION Resolution: 2.01 Å Organism(s): Mycobacterium Tuberculosis Sequences Data: 5KWJ_A , 5KWJ_B
M.tb antigen 85c acyl-enzyme intermediate with tetrahydrolipstatin Deposition Author(s): Goins, C.M. , Ronning, D.R.
Date: 2017-05-01 Method: X-RAY DIFFRACTION Resolution: 1.45 Å Organism(s): Mycobacterium Tuberculosis Sequences Data: 5VNS_A
Mtb rv3802c with peg bound Deposition Author(s): Goins, C.M. , Ronning, D.R. , Schreidah, C.M.
Date: 2017-06-22 Method: X-RAY DIFFRACTION Resolution: 1.723 Å Organism(s): Mycobacterium Tuberculosis Sequences Data: 5W95_A , 5W95_B
Sars-cov-2 3clpro in complex with 2-(benzotriazol-1-yl)-n-[4-(1h-pyrazol-4-yl)phenyl]-n-(3-thienylmethyl)acetamide Deposition Author(s): Arya, T. , Goins, C.M. , Macdonald, J.D. , Stauffer, S.R.
Date: 2021-02-05 Method: X-RAY DIFFRACTION Resolution: 1.96 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2 Sequences Data: 7LMD_A
Sars-cov-2 3clpro in complex with n-[4-[[2-(benzotriazol-1-yl)acetyl]-(3-thienylmethyl)amino]phenyl]cyclopropanecarboxamide Deposition Author(s): Arya, T. , Goins, C.M. , Macdonald, J.D. , Stauffer, S.R.
Date: 2021-02-05 Method: X-RAY DIFFRACTION Resolution: 2.1 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2 Sequences Data: 7LME_A , 7LME_B
Sars-cov-2 3clpro in complex with 2-(benzotriazol-1-yl)-n-[4-(1h-imidazol-4-yl)phenyl]-n-(3-thienylmethyl)acetamide Deposition Author(s): Arya, T. , Goins, C.M. , Macdonald, J.D. , Stauffer, S.R.
Date: 2021-02-05 Method: X-RAY DIFFRACTION Resolution: 2.2 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2 Sequences Data: 7LMF_A , 7LMF_B
Sars-cov-1 3clpro in complex with n-(4-(1h-imidazol-4-yl)phenyl)-2-(1h-benzo[d][1,2,3]triazol-1-yl)-n-(thiophen-3-ylmethyl)acetamide Deposition Author(s): Arya, T. , Goins, C.M. , Macdonald, J.D. , Stauffer, S.R.
Date: 2021-02-05 Method: X-RAY DIFFRACTION Resolution: 1.6 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus Sequences Data: 7LMG_AAA
Sars-cov-1 3clpro in complex with 2-(1h-benzo[d][1,2,3]triazol-1-yl)-n-(4-(pyridin-3-yl)phenyl)-n-(thiophen-3-ylmethyl)acetamide Deposition Author(s): Arya, T. , Goins, C.M. , Macdonald, J.D. , Stauffer, S.R.
Date: 2021-02-05 Method: X-RAY DIFFRACTION Resolution: 1.85 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus Sequences Data: 7LMH_AAA
Sars-cov-1 3clpro in complex with n-(4-(1h-pyrazol-4-yl)phenyl)-2-(1h-benzo[d][1,2,3]triazol-1-yl)-n-(thiophen-3-ylmethyl)acetamide Deposition Author(s): Arya, T. , Goins, C.M. , Macdonald, J.D. , Stauffer, S.R.
Date: 2021-02-05 Method: X-RAY DIFFRACTION Resolution: 1.707 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus Sequences Data: 7LMI_AAA